These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28824637)

  • 41. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.
    Robak T; Robak P
    Int Rev Immunol; 2013 Aug; 32(4):358-76. PubMed ID: 23617253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
    Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
    Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
    Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
    J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
    Stevenson FK; Forconi F; Packham G
    Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin's B cell lymphomas.
    Kipps TJ
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):293-8. PubMed ID: 3065730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical influences on the pathogenesis of follicular lymphoma.
    Küppers R; Stevenson FK
    Blood; 2018 May; 131(21):2297-2306. PubMed ID: 29666116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
    Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
    Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation.
    Heinig K; Gätjen M; Grau M; Stache V; Anagnostopoulos I; Gerlach K; Niesner RA; Cseresnyes Z; Hauser AE; Lenz P; Hehlgans T; Brink R; Westermann J; Dörken B; Lipp M; Lenz G; Rehm A; Höpken UE
    Cancer Discov; 2014 Dec; 4(12):1448-65. PubMed ID: 25252690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin.
    Gerousi M; Laidou S; Gemenetzi K; Stamatopoulos K; Chatzidimitriou A
    Front Oncol; 2021; 11():771454. PubMed ID: 34804974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-Glycosylation of the Ig Receptors Shapes the Antigen Reactivity in Chronic Lymphocytic Leukemia Subset #201.
    Iatrou A; Gounari M; Sofou E; Zaragoza-Infante L; Markopoulos I; Sarrigeorgiou I; Petrakis G; Pechlivanis N; Roumeliotou-Dimou M; Panayiotidis P; Stamatopoulos B; Gkanidou M; Sandaltzopoulos R; Degano M; Koletsa T; Lymberi P; Psomopoulos F; Ghia P; Agathangelidis A; Chatzidimitriou A; Stamatopoulos K
    J Immunol; 2023 Sep; 211(5):743-754. PubMed ID: 37466373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging roles of protein mannosylation in inflammation and infection.
    Loke I; Kolarich D; Packer NH; Thaysen-Andersen M
    Mol Aspects Med; 2016 Oct; 51():31-55. PubMed ID: 27086127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?
    Allen JC; Talab F; Slupsky JR
    Int J Hematol Oncol; 2016 May; 5(1):37-53. PubMed ID: 30302202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in understanding the biology of follicular lymphoma.
    Nishikori M
    Int J Hematol; 2024 Mar; ():. PubMed ID: 38536645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lectin Drug Conjugates Targeting High Mannose N-Glycans.
    Kurhade SE; Ross P; Gao FP; Farrell MP
    Chembiochem; 2022 Oct; 23(19):e202200266. PubMed ID: 35816406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thermodynamics-Guided Design Reveals a Cooperative Hydrogen Bond in DC-SIGN-targeted Glycomimetics.
    Nemli DD; Jiang X; Jakob RP; Gloder LM; Schwardt O; Rabbani S; Maier T; Ernst B; Cramer J
    J Med Chem; 2024 Aug; 67(16):13813-13828. PubMed ID: 38771131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR screens and lectin microarrays identify novel high mannose N-glycan regulators.
    Tsui CK; Twells N; Doan E; Woo J; Khosrojerdi N; Brooks J; Kulepa A; Webster B; Mahal LK; Dillin A
    bioRxiv; 2024 Apr; ():. PubMed ID: 37961200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling.
    Huang A; Kurhade SE; Ross P; Apley KD; Griffin JD; Berkland CJ; Farrell MP
    ACS Pharmacol Transl Sci; 2022 Nov; 5(11):1062-1069. PubMed ID: 36407961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.